US Broker Ratings

Moderna, Inc. (MRNA) Stock Analysis: Insights into its 6.71% Potential Upside Despite Revenue Challenges

Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, has captured the attention of investors with its innovative approach to messenger RNA (mRNA) medicines. Headquartered in Cambridge, Massachusetts,..

Qiagen N.V. (QGEN) Stock Analysis: Exploring a 9.81% Upside in the Diagnostics Sector

Qiagen N.V. (NYSE: QGEN) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Venlo, Netherlands, Qiagen is known for offering a comprehensive..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Healthcare Distribution with a $9.42 Billion Market Cap

Henry Schein, Inc. (NASDAQ: HSIC) stands as a formidable player in the healthcare distribution sector, offering a diverse range of products and services that cater to dental and medical practitioners..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 22.84% Potential Upside in Biotech Innovations

Roivant Sciences Ltd. (NASDAQ: ROIV) is capturing the attention of investors with its ambitious efforts in the biotechnology sector, despite a challenging financial landscape. Based in London, this clinical-stage biopharmaceutical..

Option Care Health, Inc. (OPCH) Stock Analysis: A 16% Upside Potential in the Healthcare Sector

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the medical care facilities industry, is making waves with its robust growth potential and strategic positioning within the healthcare sector...

AptarGroup, Inc. (ATR) Stock Analysis: Eyeing a 28.5% Upside with Strong Analyst Support

For investors seeking a compelling opportunity in the healthcare sector, AptarGroup, Inc. (NYSE: ATR) presents a noteworthy case. Known for its innovative solutions in drug delivery and consumer product dispensing,..

Agilent Technologies, Inc. (A) Investor Outlook: Potential 13.51% Upside Amid Robust Growth and Solid Buy Ratings

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, is making waves with its compelling growth story and favorable analyst ratings. As a leader in the diagnostics..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Promising Biotech with 22% Revenue Growth and Strong Buy Ratings

Halozyme Therapeutics, Inc. (NASDAQ: HALO) has emerged as a significant player in the biotechnology sector, capturing investor attention with its innovative enzyme-based technologies and robust financial performance. With a market..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Exploring a 52% Potential Upside with Strong Buy Ratings

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a leader in the biotechnology sector, is a company that has caught the attention of investors with its focus on rare disease therapies and a..

Revvity, Inc. (RVTY) Stock Analysis: Exploring a 9.76% Potential Upside in the Healthcare Sector

Revvity, Inc. (NYSE: RVTY) stands as a formidable player in the healthcare sector, specializing in diagnostics and research. With a market capitalization of $12.12 billion, this U.S.-based company is carving..

Exact Sciences Corporation (EXAS) Stock Analysis: Strong Revenue Growth Amid High Valuation

Exact Sciences Corporation (NASDAQ: EXAS) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $19.38 billion, this U.S.-based company is..

The Cigna Group (CI) Stock Analysis: Exploring a 17.2% Potential Upside and Robust Analyst Support

The Cigna Group (NYSE: CI), a stalwart in the healthcare industry, presents a compelling investment opportunity with significant potential upside. Operating in the Healthcare Plans industry, this Connecticut-based company has..

Mettler-Toledo International, Inc. (MTD): Investor Outlook on Valuation and Growth Potential

Mettler-Toledo International, Inc. (NYSE: MTD) is a prominent player in the healthcare sector, specializing in diagnostics and research. Headquartered in Columbus, Ohio, this company has established a formidable presence in..

Viatris Inc. (VTRS) Stock Analysis: Navigating the Opportunities within Healthcare’s Dynamic Landscape

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, operates as a versatile global entity in the drug manufacturing industry. Specializing in both specialty and generic drugs, Viatris..

Teleflex Incorporated (TFX) Stock Analysis: Navigating the Medical Device Market with a 16.38% Upside Potential

Investors eyeing opportunities in the healthcare sector may find Teleflex Incorporated (NYSE: TFX) an intriguing prospect. As a key player in the medical instruments and supplies industry, Teleflex has established..

BeOne Medicines Ltd. (ONC) Stock Analysis: Exploring a Potential 19% Upside in the Biotechnology Sector

BeOne Medicines Ltd. (ONC), a Swiss-based biotechnology firm, has garnered significant attention in the healthcare sector, particularly among investors seeking growth opportunities in oncology treatments. The company, formerly known as..

Insulet Corporation (PODD) Stock Analysis: A 29.95% Potential Upside with Strong Buy Ratings

Investors eyeing opportunities in the medical devices sector might find Insulet Corporation (NASDAQ: PODD) an intriguing prospect. As a pioneering force in insulin delivery systems, Insulet’s cutting-edge technology and robust..

Royalty Pharma plc (RPRX) Stock Analysis: Strong Buy Ratings and a 15% Potential Upside

Royalty Pharma plc (NASDAQ: RPRX), a prominent player in the biotechnology sector, offers investors an intriguing proposition with its innovative model of acquiring biopharmaceutical royalties. With a substantial market cap..

Glaukos Corporation (GKOS) Stock Analysis: Unpacking a 38.10% Revenue Growth with Potential 13.86% Upside

Investors looking into the healthcare sector, particularly in the niche of medical devices, will find Glaukos Corporation (NYSE: GKOS) an intriguing prospect. This ophthalmic pharmaceutical and medical technology company has..

Cencora, Inc. (COR) Stock Analysis: Exploring a 15.56% Potential Upside Amid Strong Analyst Confidence

Cencora, Inc. (NYSE: COR), a towering figure in the healthcare sector, has drawn significant investor attention with its robust market cap of $65.12 billion and promising growth potential. Following its..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds